About us
- >
- About us >
- Information >
- Announcement
Announcement
-
2021-07-02Energenesis Biomedical Announces Positive End-of-Phase 2 Meeting with FDA on ENERGI-F703 for the Treatment of Diabetic Foot Ulcers
-
2021-04-19The Japan patent “Compound for Activating AMPK and Used Thereof” is granted.
-
2021-02-18The Korean patent “Compound for Activating AMPK and Used Thereof” is granted.
-
2020-12-11The Canada patent “Compound for Activating AMPK and Used Thereof” is granted.
-
2020-12-01Energenesis Biomedical won the 17th National Innovation Award-Enterprise Innovation Award
-
2020-11-12Energenesis Biomedical (TWO: 6657) was awarded one of the "TOP Wound Care Solution Providers" by MED TECH OUTLOOK.
-
2020-10-08The IND application of ENERGI-F703 for treating venous leg ulcers (VLU) has been approved by TFDA.
-
2020-09-21The Australian patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
2020-06-24The Singapore patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
2020-05-07The Turk patent “Composition for promoting hair growth” is granted